These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11004671)

  • 1. Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival.
    Helland A; Kraggerud SM; Kristensen GB; Holm R; Abeler VM; Huebner K; Borresen-Dale AL; Lothe RA
    Int J Cancer; 2000 Oct; 88(2):217-22. PubMed ID: 11004671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis.
    Kraggerud SM; Aman P; Holm R; Stenwig AE; Fosså SD; Nesland JM; Lothe RA
    Cancer Res; 2002 Jan; 62(2):512-7. PubMed ID: 11809703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.
    Herzog CR; Crist KA; Sabourin CL; Kelloff GJ; Boone CW; Stoner GD; You M
    Mol Carcinog; 2001 Mar; 30(3):159-68. PubMed ID: 11301476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
    Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
    Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
    J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma.
    Wistuba II; Montellano FD; Milchgrub S; Virmani AK; Behrens C; Chen H; Ahmadian M; Nowak JA; Muller C; Minna JD; Gazdar AF
    Cancer Res; 1997 Aug; 57(15):3154-8. PubMed ID: 9242443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.
    Connolly DC; Greenspan DL; Wu R; Ren X; Dunn RL; Shah KV; Jones RW; Bosch FX; Muñoz N; Cho KR
    Clin Cancer Res; 2000 Sep; 6(9):3505-10. PubMed ID: 10999736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
    Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix.
    Yoshino K; Enomoto T; Nakamura T; Nakashima R; Wada H; Saitoh J; Noda K; Murata Y
    Int J Cancer; 1998 Apr; 76(2):176-81. PubMed ID: 9537577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors.
    Frank S; Müller J; Plaschke J; Hahn M; Hampl J; Hampl M; Pistorius S; Schackert G; Schackert HK
    Cancer Res; 1997 Jul; 57(13):2638-41. PubMed ID: 9205070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
    Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
    Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FHIT gene in oral squamous cell carcinoma: allelic imbalance is frequent but cDNA aberrations are uncommon.
    Pateromichelakis S; Lee G; Langdon JD; Partridge M
    Oral Oncol; 2000 Mar; 36(2):180-8. PubMed ID: 10745170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.
    Sükösd F; Kuroda N; Beothe T; Kaur AP; Kovacs G
    Cancer Res; 2003 Jan; 63(2):455-7. PubMed ID: 12543802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion mapping of chromosome 3p and 13q and preliminary analysis of the FHIT gene in human nonmelanoma skin cancer.
    Sikkink SK; Rehman I; Rees JL
    J Invest Dermatol; 1997 Dec; 109(6):801-5. PubMed ID: 9406824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution analysis of chromosome 3p alterations in cervical carcinoma.
    Larson AA; Kern S; Curtiss S; Gordon R; Cavenee WK; Hampton GM
    Cancer Res; 1997 Sep; 57(18):4082-90. PubMed ID: 9307297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.